MMWR Reports & Recommendations

MMWR Vol. 49/No. RR-10
October 20, 2000
Contact: Clare Dykewicz, M.D.
CDC, National Center for Infectious Diseases
(404) 639–4932

Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients: Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation

These guidelines were created with the assistance of a working group of experts in infectious diseases, transplantation, and public health. For the purposes of this report, hematopoietic stem cell transplant (HSCT) is defined as any transplantation of blood- or marrow-derived hematopoietic stem cells, regardless of transplant type (i.e., allogeneic or autologous) or cell source (i.e., bone marrow, peripheral blood, or placental or umbilical cord blood). The guidelines were developed for use by HSCT recipients, their household and close contacts, transplant and infectious diseases physicians, HSCT center personnel, and public health professionals.

Media Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed October 20, 2000
URL:

Centers for Disease Control and Prevention